Griffin Asset Management Inc. Sells 89 Shares of Danaher Co. (NYSE:DHR)

Griffin Asset Management Inc. lowered its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 0.2% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 50,588 shares of the conglomerate’s stock after selling 89 shares during the period. Danaher makes up 1.4% of Griffin Asset Management Inc.’s investment portfolio, making the stock its 19th biggest holding. Griffin Asset Management Inc.’s holdings in Danaher were worth $11,612,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Decker Retirement Planning Inc. bought a new stake in Danaher in the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in Danaher in the 3rd quarter valued at about $39,000. MidAtlantic Capital Management Inc. bought a new position in Danaher in the 3rd quarter worth approximately $40,000. FSA Wealth Management LLC acquired a new position in shares of Danaher during the third quarter valued at $50,000. Finally, Darwin Wealth Management LLC acquired a new position in Danaher during the 3rd quarter valued at about $55,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR stock opened at $250.51 on Tuesday. The company’s fifty day moving average price is $235.33 and its 200-day moving average price is $253.62. Danaher Co. has a one year low of $225.42 and a one year high of $281.70. The company has a market capitalization of $180.94 billion, a PE ratio of 47.81, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. Danaher’s payout ratio is 20.61%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Guggenheim assumed coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. TD Cowen lifted their target price on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a report on Friday, December 13th. Evercore ISI raised their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, Stephens restated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $285.55.

Check Out Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.